InvestSMART

Oneview Healthcare Plc (ASX:ONE)

ALERT: Price-sensitive ASX Announcement for ONE
Current share price for ONE : $0.165 -0.085 (-34%)+
Announcement
Release
25 Jul 2025 8:19AM
Price at Release
$0.250
Full Release
download
Summary
Oneview Healthcare Plc has released its Quarterly Activities and Appendix 4C Cash Flow Report for the quarter ending March 31, 2024. The report highlights key operational achievements, including a record quarter for annual recurring revenue, several new contract wins, and the renewal or expansion of key agreements in the US and Australia. The company reported positive net cash flow for the quarter, supported by a grant payment from the Irish government, and maintains a strong cash position. Oneview continues to invest in its platform, focusing on AI-driven solutions and new features to increase patient engagement and expand its capabilities within the acute care sector. The company's outlook remains positive, with ongoing sales momentum, continued product innovation, and a robust sales pipeline.
Key Points
  • Record quarter for annual recurring revenue (ARR), reaching USD 13.7m.
  • Signed new contracts with Northern Health (Australia), Children’s Health Orange County (California), and expansion at Adventist Health White Memorial (California).
  • Renewed agreements with NYU Langone Health and Epworth HealthCare.
  • Received €1.4 million grant payment from the Irish government, contributing to positive net cash flow.
  • Net cash inflow from operating activities: €1.2 million.
  • Quarter-end cash: €6.5 million, with no debt.
  • Product innovation efforts focused on AI and patient engagement solutions.
  • Continued investment in sales and marketing, resulting in a strong sales pipeline.
  • Management expects continued revenue growth and positive outlook for the coming quarters.
  • Appendix 4C included, outlining cash flows for the quarter and confirming sufficient funding for at least two quarters.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.